IS-27 A New Therapeutical Approach : Topotecan Plus Gemcitabine In The Treatment Of Patients With Relapsed Ovarian Cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 2002-02-01
著者
-
Stengel D.
Department Of Gynecology And Obstetrics Chante Medical University Berlin
-
Camara O.
The Ovarian Cancer Working Group Of The North-eastern-society Of Gynaecological Oncology (noggo)
-
Klare P.
Department Of Gynecology And Obstetrics Chante Medical University Berlin
-
Sehouli J.
Department Of Gynecology And Obstetrics Campus Virchow-klinkum Charite Medical University Berlin
-
Oskay G.
Department Of Gynecology And Obstetrics Chante Medical University Berlin
-
Lichtenegger W.
Department Of Gynecology And Obstetrics Campus Virchow-klinkum Charite Medical University Berlin
関連論文
- Primary Mucinous Adenocarcinoma of the Appendix : A Rare Entity in the Differential Diagnosis of Ovarian Cancer
- P1-IS-41 Final results of a randomized multicenter phase III trial in 505 patients with relapsed ovarian cancer : topotecan monotherapy versus topotecan + etoposide versus topotecan + gemcitabine
- IS-27 A New Therapeutical Approach : Topotecan Plus Gemcitabine In The Treatment Of Patients With Relapsed Ovarian Cancer
- Weekly taxol (T) and carboplatin (P) as first-line therapy in advanced ovarian cancer (AOC) : overall survival data of a phase ii-study in 130 patients(Oncology 1)
- Operative results after primary and secondary debulking-operation in advanced ovarian cancer
- 4. Long-Term Results of Multivisceral Surgery in Patients with Recurrent Ovarian Cancer(IV. Recent Advances in Gynecological Oncology,International Symposium)
- The Vaginal Radical Operation of Cervical Cancer